Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu
  • quotes

  • charts

  • technicals

  • company

Aequus Pharmaceuticals Inc (AQSZF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1763 +12.65%
on 05/15/18
0.2374 -16.34%
on 05/04/18
-0.0117 (-5.56%)
since 04/25/18
3-Month
0.1763 +12.65%
on 05/15/18
0.2620 -24.20%
on 03/09/18
-0.0554 (-21.81%)
since 02/23/18
52-Week
0.1150 +72.70%
on 09/18/17
0.3560 -44.21%
on 01/12/18
-0.0014 (-0.70%)
since 05/25/17

Most Recent Stories

More News
Aequus Announces Official Launch of Zepto Capsulotomy System in Canada to be June 1, 2018

Aequus Pharmaceuticals Inc. (TSX-V:AQS) (OTCQB:AQSZF) ("Aequus" or the "Company"), is pleased to announce it will be formally launching the Zepto Precision Pulse Capsulotomy System ("Zepto") in Canada...

AQS.VN : 0.250 (-1.96%)
AQSZF : 0.1986 (-0.55%)
Aequus and Camargo Complete Pre-Investigational New Drug Submission with FDA for Transdermal Anti-Nausea Program

Aequus Pharmaceuticals Inc. (TSX-V:AQS) (OTCQB:AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, announced...

AQS.VN : 0.250 (-1.96%)
AQSZF : 0.1986 (-0.55%)
Edible Electronic Circuits Could be a Medical Revolution in the Waiting

FN Media Group Presents USA News Group News Commentary

AQS.VN : 0.250 (-1.96%)
AQSZF : 0.1986 (-0.55%)
BSX : 30.31 (-0.30%)
SUPN : 57.25 (+2.88%)
BDX : 223.73 (-0.83%)
BAX : 72.53 (+0.17%)
CORI : 8.43 (-0.94%)
AXSM : 3.35 (+3.08%)
Aequus Adds Zepto Capsulotomy System, A Revenue Generating Product, to Commercial Ophthalmology Portfolio

Aequus Pharmaceuticals Inc. (TSX-V:AQS) (OTCQB:AQSZF) ("Aequus" or the "Company"), is pleased to announce it has entered into a commercial agreement with Mynosys Cellular Devices, an ophthalmology focused...

AQS.VN : 0.250 (-1.96%)
AQSZF : 0.1986 (-0.55%)
Aequus Expands Market in Quebec for Tacrolimus IR

Aequus Pharmaceuticals Inc. (TSX-V:AQS) (OTCQB:AQSZF) ("Aequus" or the "Company"), announced today that it has been awarded a three-year contract with Sigma Sante for its partnered product, tacrolimus...

AQS.VN : 0.250 (-1.96%)
AQSZF : 0.1986 (-0.55%)
FDA Confirms Date to Providing Regulatory Guidance for Aequus' Anti-Nausea Patch

Aequus Pharmaceuticals Inc. (TSX-V:AQS) (OTCQB:AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, announced...

AQS.VN : 0.250 (-1.96%)
AQSZF : 0.1986 (-0.55%)
TSX Venture Exchange Bulletins

TSX VENTURE COMPANIES

AQSZF : 0.1986 (-0.55%)
Aequus Announces Proposed $300,000 Equity Financing

VANCOUVER, BC--(Marketwired - January 11, 2018) -

AQS.VN : 0.250 (-1.96%)
AQSZF : 0.1986 (-0.55%)
CannaRoyalty and Aequus Pharmaceuticals Announce Joint Venture to Develop and Commercialize Cannabis-Based Therapies Targeting Neurological Disorders

CannaRoyalty to contribute Bodhi Research position into the JV in exchange for equity

CNNRF : 4.0900 (-0.53%)
AQS.VN : 0.250 (-1.96%)
AQSZF : 0.1986 (-0.55%)
CRZ.CN : 5.300 (-0.56%)
CannaRoyalty and Aequus Pharmaceuticals Announce Joint Venture to Develop and Commercialize Cannabis-Based Therapies Targeting Neurological Disorders

CannaRoyalty to contribute Bodhi Research position into the JV in exchange for equity

CNNRF : 4.0900 (-0.53%)
AQSZF : 0.1986 (-0.55%)
AQS.VN : 0.250 (-1.96%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade AQSZF with:

Key Turning Points

2nd Resistance Point 0.2015
1st Resistance Point 0.2001
Last Price 0.1986
1st Support Level 0.1971
2nd Support Level 0.1955

See More

52-Week High 0.3560
Fibonacci 61.8% 0.2639
Fibonacci 50% 0.2355
Fibonacci 38.2% 0.2071
Last Price 0.1986
52-Week Low 0.1150

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar